Non-Small Cell Lung Cancer
Conditions
Keywords
non-small cell lung cancer
Brief summary
Medical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. Participating in an observational clinical trial may help patients with non-small cell lung cancer since it advances medical knowledge and may improve treatment choices in the future.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participant has a diagnosis of non-small cell lung cancer * Patient has self-identified as planning to enroll in a clinical trial for non-small cell lung cancer * Patient is at least 18 years of age
Exclusion criteria
* Inability to perform regular electronic reporting * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial * Pregnant or lactating woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a non-small cell lung cancer clinical study. | 3 months |
| Number of non-small cell lung cancer patients who remain in clinical trial until completion. | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed